Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
Tags: immunotherapy | rheumatoid | arthritis | cardiovascular | risk

Immunotherapy May Reduce Heart Risk in Arthritis

Immunotherapy May Reduce Heart Risk in Arthritis
(Copyright DPC)

Monday, 11 July 2016 02:53 PM EDT

People with rheumatoid arthritis are at higher risk of heart disease but immunotherapy may help reduce it, a new study shows.

Rhumatoid arthritis (RA) is an autoimmune disease in which the immune system, which normally protects the body, turns on it, leading to painful and inflamed joints. People with RA also have a higher level of inflammation generally, which is believed to play a role in their higher risk of cardiovascular disease.

Among the substances that cause this inflammation are cytokines, particularly " necrosis factor (TNF) and interferon (IFN), which normally protect the body, but, in RA, attack healthy cells, and leads to the higher cardiovascular risk.

In previous research, Dr. Aida Babaeva, a Russian researcher at Volgograd State Medical University, demonstrated that treatment with immunological drugs lowers these cytokines.

The researchers found that those taking the combination of anticytokines had a lower rheumatoid arthritis disease activity score, and a decrease in inflammatory factors more than the group on standard therapy alone.  In addition, the incidence of cardiovascular events (unstable angina, severe high blood pressure and a worsening of chronic heart failure) was more than double in the group on conventional disease-modifying drugs alone (37 percent) compared to those also taking the combination of anticytokines (13 percent).

The study does not mean that all patients with RA should receive the extra low-dose antocytokines drugs, but it does indicate the approach should be considered for the prevention of cardiovascular events in patients not receiving immunotherapy and who do not have severe complications, Babaeva says of the study, which was presented to the European Society of Cardiology.

© 2024 NewsmaxHealth. All rights reserved.

A new study finds that immunotherapy drugs may reduce the risk of cardiovascular disease in people with rheumatoid arthritis.
immunotherapy, rheumatoid, arthritis, cardiovascular, risk
Monday, 11 July 2016 02:53 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
Find Your Condition
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved